Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels

This study has been withdrawn prior to enrollment.
(Unable to find eligible subjects- study closed)
Sponsor:
Collaborator:
Novartis
Information provided by:
National Jewish Health
ClinicalTrials.gov Identifier:
NCT00851370
First received: February 4, 2009
Last updated: April 14, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2011
  Estimated Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)